Mainolfi stated, "We shared outstanding results from both our Phase I healthy volunteer study and our Phase Ib study in AD patients... KT-621 has the potential to deliver robust efficacy in line with ...
Poster published at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting shows the final 5 year safety data from the Phase IIb breast cancer clinical trial. Final safety conclusions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results